- Novel heterocyclic compounds as mGlu5 antagonists: WO2009015897
[作者:Doller, D; Li, GY; Brodbeck, RM; Thomsen, C,期刊:Expert Opinion on Therapeutic Patents, 页码:435-439 , 文章类型: Article,,卷期:2010年20-3]
- Metabotropic glutamate receptor 5 (mGlu5) negative allosteric modulators (NAMs) have previously been implicated in a number of pathophysiological conditions, based on preclinical, and to some extent clinical, proof of co...
|